当前位置：首页 > 文献互助 > 互助详情

Design, Preclinical Evaluation, and Clinical Translation of [68Ga]Ga/[177Lu]Lu-JH120061, A Novel Radiopharmaceutical Targeting CXCR4复制

用户MMp1aIcztvik 1小时前 13 10 求助中 帖子自动结束时间: 2026-07-07 19:40:16

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1158/1078-0432.ccr-26-0292复制

文献链接: https://aacrjournals.org/clincancerres/article/doi/10.1158/1078-0432.CCR-26-0292/785484/Design-Preclinical-Evaluation-and-Clinical复制

其他信息:

出版社: American Association for Cancer Research (AACR)
作者: Guochang Wang; Tianrui Kang; Yumeng Peng; Shaohao Chen; Xingting Chen; Xiuting Lin; Yuxin Lai; Jian Zhan; Yaoming Yu; Ruihong Li; Haihua Yu; Eric Wang; Jinqiu He; Chunlin Ke; Jie Zang; Ning Xu; Weibing Miao
全文下载地址: https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-26-0292/3798530/ccr-26-0292.pdf

上一篇：Covalent organic frameworks (COFs): from design to applications

互助时间线

2026-07-02 19:41:15 [驳回应助]

楼主驳回了研究小站应助的文件, 求助状态回到 求助中

备注: 想要补充文件

2026-07-02 19:40:26 [上传文件]

研究小站上传了文件(pdf 2.24 MB), 求助状态变成 待确认

2026-07-02 19:40:16 [发起求助]

最新发布的求助

Design, Preclinical Evaluation, and Clinical Translation of [68Ga]Ga/[177Lu]Lu-JH120061, A Novel Radiopharmaceutical Targeting CXCR4 1小时前
Covalent organic frameworks (COFs): from design to applications 2小时前
Neuroprotective effects of Gastrodia elata and its compounds in a Caenorhabditis elegans Alzheimer’s disease model 3小时前
Baicalin alleviates pathological changes in Alzheimer's disease comorbid with type 2 diabetes: Targeting metabolic dysregulation and neuroinflammation 3小时前
Integrated untargeted and targeted metabolomics to reveal the mechanisms of herbal medicine HLXLD on Alzheimer's disease 3小时前
Dihuang Yinzi Regulates cAMP/PKA/CREB-BDNF to Improve Synaptic Plasticity in APP/PS1 Mice: A Study Based on Brain Metabolomics 3小时前
Total Lignans From Leaves of Schisandra chinensis Improve Alzheimer's Disease Pathology Through the Nrf2/HO-1/NLRP3 Pathway 3小时前
RANQSAR: a standalone open-source application for reproducible machine learning-based QSAR analysis 3小时前
Efficacy and safety of Ivarmacitinib in moderate-to-severe atopic dermatitis patients with or without previous systemic treatments: a post-hoc analysis of a phase III trial 3小时前
24-Week Real-World Effectiveness and Safety of Lebrikizumab for Atopic Dermatitis in Japan: An Analysis Stratified by Prior Systemic Therapy 3小时前
48-Week Real-World Outcomes of Lebrikizumab Treatment for Atopic Dermatitis: Systemic Therapy-Naive Versus -Experienced Patients 4小时前
Resolving cellular dynamics using single-cell temporal transcriptomics 4小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com